IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries.
Financial Statements
- Click here to download Idexx Laboratories, Inc.'s Income Statement
- Click here to download Idexx Laboratories, Inc.'s Balance Sheet
- Click here to download Idexx Laboratories, Inc.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Jonathan Jay Mazelsky
Key Statistics
- Stock Price: $532.32
- Dividend Yield: 0%
- Market Capitalization: $44,015,934,458
- Shares Outstanding: 84,249,085
- Number of Employees: 9,300
- Trailing 12-Month EPS: $8.6
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2022-05-04
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $532.32
- 52-week high: $706.95
- 52-week low: $460.36
- 200-day moving average: $608.94
- 50-day moving average: $513.16
Performance
- 1-Month Price Return: 10.9%
- 3-Month Price Return: -14.0%
- 6-Month Price Return: -21.8%
- 1-Year Price Return: 0.4%
- 2-Year Price Return: 108.9%
- 5-Year Price Return: 263.8%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast